How many studies have been conducted on Cd30 Ligand?

BiohacksAI has indexed 133 PubMed studies on Cd30 Ligand. 25% of studies involve human subjects.

What are the main research areas for Cd30 Ligand?

The primary research domains for Cd30 Ligand are 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 133 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cd30 Ligand

A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.

133+ PubMed studies analyzed · Evidence Score: 43.8

Research Domains

Cd30 Ligand has been studied across 13 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, ✨ Skin & Hair, 🧠 Memory. The primary research focus is 🔬 Oncology with 56% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd30 Ligand is generated deterministically from 133 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.